Bausch Health Companies (BHC) Equity Average (2010 - 2026)

Bausch Health Companies has disclosed Equity Average across 17 years of filings, most recently posting -$841.0 million for Q1 2026.

• Equity Average for Q1 2026 came in at -$841.0 million, down 10.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$841.0 million (down 10.73% YoY), and the FY2025 annual result was -$451.0 million, up 33.73% from the prior year.
• Equity Average came in at -$841.0 million for Q1 2026 at Bausch Health Companies, down from $366.5 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $366.5 million in Q4 2025 to a low of -$841.0 million in Q1 2026.
• The 5-year median for Equity Average is -$46.5 million (2025), against an average of -$83.8 million.
• Across the five-year window, Equity Average surged 510.06% in 2022 and slumped 1402.78% in 2024, its largest moves.
• Bausch Health Companies' Equity Average stood at $346.5 million in 2022, then slumped by 145.74% to -$158.5 million in 2023, then plunged by 379.81% to -$760.5 million in 2024, then soared by 148.19% to $366.5 million in 2025, then slumped by 329.47% to -$841.0 million in 2026.
• The last three Equity Average figures came in at -$841.0 million (Q1 2026), $366.5 million (Q4 2025), and $251.5 million (Q3 2025), per Business Quant data.